$MTH

Meritage Homes CORP

0
0
4

No SEC Form 4 filings for $MTH in the last 30 days.

See all $MTH insider activity →
Low

Starbucks initiated, Expedia downgraded: Wall Street's top analyst calls

Analysts made several rating changes: Wolfe upgraded Paychex (PAYX) citing stable employment trends. UBS upgraded Union Pacific (UNP) to Buy with a $339 price target, expecting strong 2027 volume growth. Needham upgraded Rocket Pharmaceuticals (RCKT) to Buy with a $9 target after FDA reaffirmed study design. JPMorgan upgraded Credicorp (BAP) to Overweight with a $482 target, seeing strong EPS growth. Morgan Stanley downgraded Expedia (EXPE) to Underweight with a $235 target, citing weaker assets

Why is Meritage Homes stock sliding today?

Meritage Homes (MTH) fell 2.3% premarket after Truist Securities downgraded it from Buy to Hold, cutting its price target to $72 from $80. The firm had previously rated it Buy with a $90 target. MTH's net income dropped 38% YoY last quarter, and the sector faces high mortgage rates and material costs. Competitors like D.R. Horton, Lennar, and PulteGroup also struggle with these issues.

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Airbnb, Booking Holdings, Credicorp, Dutch Bros, Expedia, Hartford Financial Services, Group, Meritage Homes, Patchex, Yum! Brands, and Mor

Wall Street analysts upgraded Credicorp (BAP) to Overweight, Paychex (PAYX) to Peer Perform, Rocket Pharmaceuticals (RCKT) to Buy, Similarweb (SMWB) to Buy, and Union Pacific (UNP) to Buy. Downgrades include Expedia (EXPE) to Underweight, Grupo Aval (AVAL) to Underweight, Hartford Financial (HIG) to Neutral, Meritage Homes (MTH) to Hold, and Nubank (NU) to Market Perform. Initiations: Airbnb (ABNB) with Equal Weight, Booking Holdings (BKNG) with Overweight, Dutch Bros (BROS) with Buy, Five9 (FIV

MTH sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 4 news stories mentioning MTH (Meritage Homes CORP). Coverage has skewed bearish: 0 bullish, 0 neutral, and 4 bearish.

Recent MTH coverage spans financial news, earnings and macro economy.

What's driving MTH

AlphAI scores every news story that mentions MTH with an AI model for sentiment and relevance, and aggregates insider trades from Meritage Homes CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $MTH

Score

Starbucks initiated, Expedia downgraded: Wall Street's top analyst calls

Analysts made several rating changes: Wolfe upgraded Paychex (PAYX) citing stable employment trends. UBS upgraded Union Pacific (UNP) to Buy with a $339 price target, expecting strong 2027 volume growth. Needham upgraded Rocket Pharmaceuticals (RCKT) to Buy with a $9 target after FDA reaffirmed study design. JPMorgan upgraded Credicorp (BAP) to Overweight with a $482 target, seeing strong EPS growth. Morgan Stanley downgraded Expedia (EXPE) to Underweight with a $235 target, citing weaker assets

$MTHMed

Why is Meritage Homes stock sliding today?

Meritage Homes (MTH) fell 2.3% premarket after Truist Securities downgraded it from Buy to Hold, cutting its price target to $72 from $80. The firm had previously rated it Buy with a $90 target. MTH's net income dropped 38% YoY last quarter, and the sector faces high mortgage rates and material costs. Competitors like D.R. Horton, Lennar, and PulteGroup also struggle with these issues.

$BAPMed

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Airbnb, Booking Holdings, Credicorp, Dutch Bros, Expedia, Hartford Financial Services, Group, Meritage Homes, Patchex, Yum! Brands, and Mor

Wall Street analysts upgraded Credicorp (BAP) to Overweight, Paychex (PAYX) to Peer Perform, Rocket Pharmaceuticals (RCKT) to Buy, Similarweb (SMWB) to Buy, and Union Pacific (UNP) to Buy. Downgrades include Expedia (EXPE) to Underweight, Grupo Aval (AVAL) to Underweight, Hartford Financial (HIG) to Neutral, Meritage Homes (MTH) to Hold, and Nubank (NU) to Market Perform. Initiations: Airbnb (ABNB) with Equal Weight, Booking Holdings (BKNG) with Overweight, Dutch Bros (BROS) with Buy, Five9 (FIV

The 5 Most Interesting Analyst Questions From Meritage Homes’s Q2 Earnings Call

Meritage Homes (MTH) reported Q2 revenue of $1.41B, down 13.8% year over year and slightly below estimates, while adjusted EPS was $1.42, above estimates. Management cited softer demand and incentive pressure, but said operational discipline supported a 200% backlog conversion rate and cycle times under 110 days. Analysts asked about margin drivers, move-up strategy, and incentive outlook.

$MTHMed

Meritage Homes CORP (MTH): Results of Operations and Financial Condition

Meritage Homes CORP (MTH) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Contacts: Emily Tadano, VP Investor Relations and External Communications (480) 515-8979 (office) investors@meritagehomes.com Meritage Homes reports second quarter 2026 results SCOTTSDALE, Ariz., July 29, 2026 - Meritage Homes Corporation (NYSE: MTH), the fifth-large

$MTHMed

Meritage Homes CORP (MTH): Entry into a Material Definitive Agreement

Meritage Homes CORP (MTH) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 ex101twelfthamendmenttocre.htm EX-10.1 Document Exhibit 10.1 TWELFTH AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT TWELFTH AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT (this “ Amendment ”) dated as of June 24, 2026, among MERITAGE HOMES CORPORATION, a Marylan

How Investors Are Reacting To Meritage Homes (MTH) Softer Q1 Results And Flat 2026 Outlook

Meritage Homes (MTH) reported softer first-quarter 2026 results with lower revenue and net income compared to the previous year, alongside flat guidance for 2026 home closing volume and revenue. This cautious outlook, combined with a recently completed share repurchase program, signals a shift in investment focus towards managing margins and navigating pricing pressures in the housing market. Despite the challenges, Simply Wall St projects a fair value for MTH with a 24% upside, while acknowledging that previous bullish analyst expectations may need reassessment given the current guidance.

Related tickers